Advertisement

Exkurs: Progressive supranukleäre Blickparese

  • G. K. Wenning
  • W. Poewe

Zusammenfassung

Steele, Richardson und Olszewksi beschrieben 1964 die nach ihnen benannte progressive supranukleäre Blickparese (progressive-supranuclear palsy — PSP) als eine klinisch-pathologisch abgrenzbare neurodegenerative Erkrankung (Steele et al. 1964). Vereinzelte klinische oder pathologische Berichte gehen jedoch z. T. um Jahrzehnte voraus (Goetz 1996). Die PSP ist neuropathologisch durch das Auftreten zahlreicher neurofibrillärer Bündel bzw. sog. „neuropil threads“ in bestimmten Regionen der Basalganglien und des Hirnstamms gekennzeichnet. Neuronaler Zellverlust und Gliose sind variabel ausgeprägt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak R (1992) Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11-C-raclopride and positron emission tomography. Ann Neurol 31: 84–192CrossRefGoogle Scholar
  2. Brücke T, Wenger S, Asenbaum S, Fertl E, Pfafflmeyer N, Muller C, Podreka I, Angelberger P (1993) Dopamine D2 receptor imaging and measurement with SPECT. Adv Neurol 60: 494–500PubMedGoogle Scholar
  3. Colosimo C, Albanese A, Hughes AJ, De Bruin V, Lees A (1995) Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson’s disease. Arch Neurol 55: 294–298CrossRefGoogle Scholar
  4. Goetz CG (1996) An early photographic case of probable progressive supranuclear palsy. Mov Disord 11: 617–618PubMedCrossRefGoogle Scholar
  5. Jankovic J (1983) Controlled trial of pergolide mesylate in Parkinson’s disease and progressive supranuclear palsy. Neurology 33: 505–507PubMedCrossRefGoogle Scholar
  6. Johnson RJ, Litvan I, Grafman J (1992) Progressive supranuclear palsy: altered sensory processing leads to degraded cognition. Neurology 41: 1257–1262CrossRefGoogle Scholar
  7. Litvan I, Chase TN (1992) Traditional and experimental therapeutic approaches. In: Litvan I, Agid Y (eds) Progressive supranuclear palsy: clinical and research approaches. Oxford University Press, New York, pp 254–269Google Scholar
  8. Litvan I, Mangone CA, Mckee A, Verny M, Parsa A, Jellinger K, D’Olhaberriague L, Chaudhuri RK, Pearce RKB (1996a) Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 61: 615–620CrossRefGoogle Scholar
  9. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D’Olhaberriague L, Verny M, Chaudhuri RK, Mckee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RKB (1996b) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46: 922–930PubMedCrossRefGoogle Scholar
  10. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996C) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1–9PubMedCrossRefGoogle Scholar
  11. Savoiardo M, Girotti F, Strada L, Cieri E (1994) Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm [Suppl] 42: 93–110CrossRefGoogle Scholar
  12. Schonfeld SM, Golbe LI, Sage JI, Safer JN, Duvoisin RC (1987) Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade. Mov Disord 2: 263–278PubMedCrossRefGoogle Scholar
  13. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333–358PubMedCrossRefGoogle Scholar
  14. Vidailhet M, Rivaud S, Gouider-Khouja N et al. (1994) Eye movements in parkinsonian syndromes. Ann Neurol 35: 420–426PubMedCrossRefGoogle Scholar
  15. Wenning GK, Pramstaller PP, Ransmayr G, Poewe W (1997) Atypische Parkinson-Syndrome. Nervenarzt 68: 102–115PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1999

Authors and Affiliations

  • G. K. Wenning
  • W. Poewe

There are no affiliations available

Personalised recommendations